These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Inflammatory bowel disease. Part II. Hansen R Proc Annu Meet Med Sect Am Counc Life Insur; 1978; ():41-9. PubMed ID: 39296 [No Abstract] [Full Text] [Related]
6. Predicting the need for azathioprine at first presentation in children with inflammatory bowel disease. Mossop H; Davies P; Murphy MS J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):123-9. PubMed ID: 18664861 [TBL] [Abstract][Full Text] [Related]
7. Refractory inflammatory bowel disease in children. Oliva-Hemker M; Escher JC; Moore D; Dubinksy M; Hildebrand H; Koda YK; Murch S; Sandhu B; Seo JK; Tanzi MN; Warner B; J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):266-72. PubMed ID: 18664886 [No Abstract] [Full Text] [Related]
8. Management of varicella infection during the course of inflammatory bowel disease. Mouzas IA; Greenstein AJ; Giannadaki E; Balasubramanian S; Manousos ON; Sachar DB Am J Gastroenterol; 1997 Sep; 92(9):1534-7. PubMed ID: 9317080 [TBL] [Abstract][Full Text] [Related]
9. The drug therapy of ulcerative colitis and of Crohn's disease. Tumen HJ Semin Drug Treat; 1974; 3(4):339-49. PubMed ID: 4150770 [No Abstract] [Full Text] [Related]
10. [Compared azathioprine efficacy in ulcerative colitis and in Crohn's disease]. Kull E; Beau P Gastroenterol Clin Biol; 2002 Apr; 26(4):367-71. PubMed ID: 12070412 [TBL] [Abstract][Full Text] [Related]
11. [Immunomodulation treatment of inflammatory bowel disease]. Stave R Tidsskr Nor Laegeforen; 1984 Jan; 104(3):153-4. PubMed ID: 6142543 [No Abstract] [Full Text] [Related]
13. Standard immunosuppression in IBD: current practice. Feagan BG Acta Gastroenterol Belg; 2001; 64(2):182-8. PubMed ID: 11475131 [No Abstract] [Full Text] [Related]
14. Inflammatory bowel disease and immune thrombocytopenic purpura: is there a correlation? Zlatanic J; Korelitz BI; Wisch N; Kim P; Ammirati M; Schwarz S; Gruenstein S; Lipsey L Am J Gastroenterol; 1997 Dec; 92(12):2285-8. PubMed ID: 9399771 [TBL] [Abstract][Full Text] [Related]
15. [Budesonide: effective, with low side effects. On the road to new treatment methods in Crohn disease]. Internist (Berl); 1998 Sep; 39(9 Suppl Auf Dem We):1-8. PubMed ID: 9772715 [No Abstract] [Full Text] [Related]
16. [Therapy of chronic inflammatory intestinal disease]. Van Gossum A Rev Med Brux; 2000 Dec; 21(6):A513-5. PubMed ID: 11194501 [No Abstract] [Full Text] [Related]
17. [Changing treatment of inflammatory bowel diseases]. Karvonen AL; Matikainen M; Turunen U Duodecim; 1994; 110(20):1945-54. PubMed ID: 7555809 [No Abstract] [Full Text] [Related]
18. Current status of drug therapy for inflammatory bowel disease. Peppercorn MA Compr Ther; 1985 Dec; 11(12):14-9. PubMed ID: 2866866 [TBL] [Abstract][Full Text] [Related]
19. Use of azathioprine in IBD: modern aspects of an old drug. Louis E; Irving P; Beaugerie L Gut; 2014 Nov; 63(11):1695-9. PubMed ID: 24943205 [No Abstract] [Full Text] [Related]
20. II. Medical treatment of inflammatory bowel disease. Gray GM Calif Med; 1973 Nov; 119(5):21-4. PubMed ID: 4148269 [No Abstract] [Full Text] [Related] [Next] [New Search]